Prologue Journal

Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges

• prologu5
• 08/21/202308/21/2023

Wall Street Journal

The generic drugmaker’s U.S. unit also must divest drug line for cholesterol treatment pravastatin.

https://www.wsj.com/articles/teva-agrees-to-pay-225-million-to-settle-u-s-price-fixing-charges-e764e8fe